Literature DB >> 21239878

Inhibition of Smad3 activity by cyclin D-CDK4 and cyclin E-CDK2 in breast cancer cells.

Fang Liu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239878

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  2 in total

Review 1.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

2.  ChIP-seq predicted estrogen receptor biding sites in human breast cancer cell line MCF7.

Authors:  Qi Li; Huichun Wang; Leyang Yu; Jun Zhou; Jingde Chen; Xia Zhang; Lin Chen; Yong Gao; Qun Li
Journal:  Tumour Biol       Date:  2014-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.